June 5, 2014

If you have it, you probably don't know it. Cytomegalovirus, or CMV, is perhaps one of the biggest pathogens you've never heard of—big, both proportionately and epidemiologically. It contains approximately 200 genes, compared to HIV's paltry 18, and it's everywhere. You can catch it as a preschooler salivating over blocks, or as a teenager experiencing your first kiss. Once you have it, you have it for life.

Good news: If you're healthy, it's harmless. Your T cells keep it in check, and you'll be none the wiser.

Bad news: If you have any medical condition that dampens your immune system, such as HIV infection or a recent organ transplant, the virus can assert itself with a vengeance. The results, sometimes, are life-threatening.

Researchers in the lab of Steven Gygi, professor of cell biology at Harvard Medical School, report that they have discovered a menu of tactical secrets CMV employs. Using a technological platform commonly used in physics and chemistry called mass spectrometry, the researchers were able to describe the dynamics of a CMV infection in a fibroblast, or connective tissue cell, over a three-day course of infection. As a result the researchers discovered ways CMV evades the immune system, and also showed how certain viral proteins target and destroy human proteins that defend against infection.

"This is an entirely new way of studying the behavior and tactics of viruses," said Gygi.

These results are published June 5 in Cell.

Mass spectrometry has existed for more than a century, used primarily by physicists and chemists to describe and measure small molecules. Inside the mass spectrometer, or mass spec tool, molecules are shattered by an electric charge and then brought through a magnetic field where they are characterized one by one.

Traditionally, this approach has not been relevant for the life sciences since biomolecules such as proteins are too large for this process. But over the last 15 years, Gygi has been innovating ways to incorporate mass spec into biology. In one approach, "electrospray," subunits of proteins called peptides are vaporized and then sprayed into a chamber where they are broken apart by helium. The mass spec then sequences the amino acids of each peptide. The molecules are "reassembled" through an algorithm that matches them to a protein database.

Michael Weekes, a postdoctoral researcher in the Gygi lab and an expert in infectious disease, decided to use mass spec for virology. He chose CMV because, for a virus that is so widespread, we actually know very little about it. "Many scientists are interested in CMV, but few if any have tried to tackle it in a comprehensive way before," he said.

Weekes took a sample of fibroblasts newly infected with CMV, harvested the proteins from both the virus and the cell, and sprayed them into the mass spec at different times over three days in order to construct a thorough trajectory of infection. The first three days of infection are particularly important since they mark a covert stage in which the virus hijacks, but hasn't yet destroyed, the cell.

The researchers were able to study approximately 8,000 total proteins, identifying not only ways that CMV evades the immune system, but also discovering a number of new therapeutic targets. Most notably, they were able to look closely at proteins that live on the cell surface. This is especially crucial since most drugs target cell surface proteins, yet these proteins are harder to study than proteins inside the cell due to their low numbers.

Weekes and his colleagues found 29 viral proteins living on the cell surface, 23 of which had not previously been discovered. Many of these CMV surface proteins deter immune cells. Others block cellular proteins that activate immunity. In other words, CMV wards off rescuers while disabling a cell's ability to defend itself.

"So much of this viral genome is dedicated to simply evading the immune system," said Weekes.

The next step, according to the researchers, would be to identify antibodies against many of these viral proteins, ideally destroying infected cells before they replicate and spread the pathogen.

An experimental vaccine against human cytomegalovirus (CMV) infection, which endangers the developing fetus, organ transplant recipients, patients with HIV and others who have a weakened immune system, proved safe and more ...

People with chronic lymphocytic leukaemia (CLL) are essentially more prone to infections such as varicella, influenza or pneumococci due to the reduction in the number of antibodies that their condition causes. Researchers ...

Infectious disease specialists at the Johns Hopkins Children's Center have identified a protein that regulates the body's immune response to cytomegalovirus (CMV), a common pathogen that causes lifelong infections and can ...

(Medical Xpress)—Experts in infection and immunity have made a path-finding discovery that could lead to the development of a vaccine for a health-ravaging virus that affects around 50% of adults in the UK.

A virus that is present in most people in a latent state may induce or exacerbate anemia in patients with kidney disease, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology ...

Many hormones and neurotransmitters work by binding to receptors on a cell's exterior surface. This activates receptors causing them to twist, turn and spark chemical reactions inside cells. NIH scientists used atomic level ...

In the last two decades, prosthetic limb technology has grown by leaps and bounds. Today, the most advanced prostheses incorporate microprocessors that work with onboard gyroscopes, accelerometers, and hydraulics to enable ...

Seeking to stem the tide of permanent hearing loss from the use of life-saving antibiotics, researchers at Oregon Health & Science University have found that patients stricken with dangerous bacterial infections are at greater ...

In a way, trying to repair age-related heart damage and trying to fight cancer are opposite problems. Your heart cells' ability to regenerate themselves and proliferate into new, young cells degrades as you get older. They ...

The lymphatic system provides a slow flow of fluid from our organs and tissues into the bloodstream. It returns fluid and proteins that leak from blood vessels, provides passage for immune and inflammatory cells from the ...

0 comments

Please sign in to add a comment.
Registration is free, and takes less than a minute.
Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.